29 It significantly affects blood glucose levels by increasing insulin release or suppressing glucagon secretion and inhibits appetite via receptors in the ventral tegmental region, nucleus accumbens, and hypothalamus
As a weight loss doctor, I often receive questions from patients about the different types of weight loss medications available and how they compare to each other
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Gibbons C., Blundell J., Tetens Hoff S., et al
Dual GLP-1/GIP agonists like tirzepatide work even better and make sense when you want to maximize results or havent achieved your goals with GLP-1 alone
Moreover, the abilities of alcohol to promote hyperlocomotion, dopamine release in the nucleus accumbens, and reward in the conditioned place preference paradigm are all suppressed by GLP-1R ligands
Cardiovascular Effects of Glucagon-like Peptide 1 Receptor Agonists: from Mechanistic Studies in Humans to Clinical Outcomes